Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Titles
NEW
 Top 50 Non-Healthcare Titles
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Immunoglobulins Global Market Report 2025
Request Sample Buy Now
Global Immunoglobulins Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Immunoglobulins Global Market Report 2025

By Product (IGG, IGA, IGM, IGE, IGD. ), By Mode Of Delivery (Intravenous Mode of Delivery, Subcutaneous Mode of Delivery), By Application (Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Immunoglobulins Market Overview

• Immunoglobulins market size has reached to $18.85 billion in 2024

• Expected to grow to $30.89 billion in 2029 at a compound annual growth rate (CAGR) of 11%

• Growth Driver: Growing Geriatric Population Fuels Demand For Immunoglobulins Market

• Market Trend: Innovative Product Launches Drive Growth in the U.S. Immunoglobulins Market

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Immunoglobulins Market?

Immunoglobins refer to glycoproteins, often known as antibodies, that are created by Plasma cells (white blood cells). They play a crucial role in the Immune response by selectively identifying and attaching to specific antigens, such as viruses or bacteria, and assisting in their eradication.

The main types of products in immunoglobulins are IGG, IGA, IGM, IGE, and IGD. Immunoglobulin G (IGG) is the primary stimulator of humoral immunity in extracellular fluids such as blood, lymph, and saliva. The immunoglobulins are delivered using the intravenous mode of delivery, subcutaneous mode of delivery and are used in hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), immunodeficiency disease, myasthenia gravis, idiopathic thrombocytopenic purpura (ITP), others.

Immunoglobulins Market Size and growth rate 2025 to 2029: Graph

What Is The Immunoglobulins Market Size 2025 And Growth Rate?

The immunoglobulins market size has grown strongly in recent years. It will grow from $18.85 billion in 2024 to $20.32 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increased prevalence of immunodeficiency disorders, growing geriatric population, rising adoption of immunoglobulins in hospitals, favorable government reimbursement plans, increasing prevalence of chronic and autoimmune diseases.

What Is The Immunoglobulins Market Growth Forecast?

The immunoglobulins market size is expected to see rapid growth in the next few years. It will grow to $30.89 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to increasing investment for the development of advanced technologies, growing awareness about immunodeficiency therapies, rising preference among physicians for immunodeficiency therapies, increasing number of emerging markets, expansion of applications in sports and fitness. Major trends in the forecast period include development of wearable and smart compression devices, customization of compression therapy solutions, integration of compression therapy in wound care management, emphasis on patient comfort and compliance in compression therapy, collaboration between manufacturers and healthcare providers for improved patient outcomes.

The forecast of 11.0% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. neurology and immunology practices by inflating prices of intravenous and subcutaneous immunoglobulin preparations imported from Germany and Norway, resulting in delayedchronic inflammatory demyelinating polyneuropathy treatment initiations and higher specialty plasma product expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Immunoglobulins Market Segmented?

1) By Product: IGG, IGA, IGM, IGE, IGD.

2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications

Subsegments:

1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin), SCIG (Subcutaneous Immunoglobulin)

2) By IGA (Immunoglobulin A): Monoclonal IGA, Polyvalent IGA

3) By IGM (Immunoglobulin M): Monoclonal IGM, Polyvalent IGM

4) By IGE (Immunoglobulin E): Allergen-Specific IGE, Monoclonal IGE

5) By IGD (Immunoglobulin D): Research-Use IGD, Monoclonal IGD

What Is Driving The Immunoglobulins Market? Growing Geriatric Population Fuels Demand For Immunoglobulins Market

The increasing geriatric population drives the growth of the immunoglobulins market. The geriatric population is at high risk of infectious diseases and auto-immune diseases. The immunoglobulin test determines the body's ability to produce antibodies that protect it from bacteria, viruses, and allergies. For instance, in October 2022, according to a report published by the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, one in six people is expected to be 60 or older by the year 2030, in the entire world. By 2050, there will be 2.1 billion people worldwide who are 60 years old or older. Thus, the increasing geriatric population is expected to increase the demand for the immunoglobulins industry during the forecast period.

What Is Driving The Immunoglobulins Market? Increasing Healthcare Expenditures Are Anticipated To Boost The Immunoglobulins Market

The increasing healthcare expenditure is expected to boost the growth of the immunoglobulins market going forward. Healthcare expenditure refers to the total amount of money spent by individuals, organizations, and governments on healthcare-related services, treatments, medications, medical equipment, facilities, and healthcare administration. Increased funding and resources in the healthcare sector drive research and development in immunoglobulins, potentially resulting in the discovery of advanced therapies that enhance market growth. For instance, in March 2022, according to the 2021–2030 National Health Expenditure (NHE) report published by the Centers for Medicare & Medicaid Services, a US-based federal agency, it was estimated that between 2021 and 2030, national health spending is going to rise by an average of 5.1% every year, reaching almost $6.8 trillion. Additionally, it is anticipated that from 2021 to 2030, Medicare spending is going to rise at a 7.2% annual pace while Medicaid spending will rise at a 5.6% annual rate. Therefore, the increasing healthcare expenditure is driving the growth of the immunoglobulins industry.

Who Are The Major Players In The Global Immunoglobulins Market?

Major companies operating in the immunoglobulins market include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited

What Are The Key Trends Of The Global Immunoglobulins Market? Innovative Product Launches Drive Growth in the U.S. Immunoglobulins Market

Major companies operating in the immunoglobulins market are developing innovative products such as intravenous immunoglobulins to meet larger customer bases, more sales, and increase revenue. For instance, in September 2024, according to the GC Biopharma, a South Korean-based biotechnology company, launched ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid in the U.S. market, targeting the treatment of primary humoral immunodeficiency (PI) in adults aged 17 years and older. now available to patients through specialty pharmacies. The launch is significant as the U.S. represents the largest immunoglobulin market globally, valued at approximately $11.6 billion. GC Biopharma aims to achieve $50 million in sales for ALYGLO in its first year, with plans to increase this figure to $300 million by 2028. This ambitious growth strategy involves partnerships with major U.S. pharmacy benefit managers and specialty pharmacies, which are crucial for distributing immunoglobulin products effectively.

What Are The Key Trends Of The Global Immunoglobulins Market? Biotest's Launch of Yimmugo in the U.S. and Long-term Collaboration with Kedrion Biopharma

Major companies operating in the immunoglobulins market are focusing on strategic partnerships such as developing advanced immunoglobulin. For instance, in June 2024, according to the Biotest, a Germany-based Biotechnology company, launch its immunoglobulin product, Yimmugo, in the United States, its FDA approval aimed at treating primary immunodeficiencies (PID). This launch is part of a strategic framework established with Kedrion Biopharma for a long-term distribution agreement projected to generate over $1 billion in revenue over seven years.The partnership requires Biotest to supply minimum quantities of Yimmugo, with preparations for its market introduction scheduled for 2025. This collaboration leverages Kedrion's extensive experience in the immunoglobulin market, addressing the needs of approximately 500,000 PID patients in the U.S. The agreement not only positions Biotest to expand its reach in the growing immunoglobulin market but also enhances patient access to essential therapies.

Need data on a specific region in this market?
Request Customisation

Immunoglobulins Market Merger And Acquisition: Abbvie Inc. Acquired DJS Antibodies Ltd.

In October 2022, AbbVie Inc., a US-based pharmaceutical company, acquired DJS Antibodies Ltd. for an undisclosed amount. The acquisition is anticipated to bring new capabilities to improve AbbVie's existing antibody research endeavours, bolster its immunology portfolio, and establish a robust presence for broader research initiatives in the thriving bioscience hub located in Oxford, UK. DJS Antibodies Ltd. is a UK-based company providing antibody therapeutics.

Regional Outlook For The Global Immunoglobulins Market

North America was the largest region in the immunoglobulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

What Defines the Immunoglobulins Market?

The immunoglobins market consists of sales of antibodies, glycoproteins, and antigens. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Immunoglobulins Industry?

The immunoglobulins market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the immunoglobulins industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Immunoglobulins Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $20.32 billion
Revenue Forecast In 2034 $30.89 billion
Growth Rate CAGR of 11% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: IGG, IGA, IGM, IGE, IGD.
2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications Subsegments: 1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin), SCIG (Subcutaneous Immunoglobulin)
2) By IGA (Immunoglobulin A): Monoclonal IGA, Polyvalent IGA
3) By IGM (Immunoglobulin M): Monoclonal IGM, Polyvalent IGM
4) By IGE (Immunoglobulin E): Allergen-Specific IGE, Monoclonal IGE
5) By IGD (Immunoglobulin D): Research-Use IGD, Monoclonal IGD
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Immunoglobulins Market Characteristics

3. Immunoglobulins Market Trends And Strategies

4. Immunoglobulins Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Immunoglobulins Growth Analysis And Strategic Analysis Framework

5.1. Global Immunoglobulins PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Immunoglobulins Market Growth Rate Analysis

5.4. Global Immunoglobulins Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Immunoglobulins Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Immunoglobulins Total Addressable Market (TAM)

6. Immunoglobulins Market Segmentation

6.1. Global Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

IGG

IGA

IGM

IGE

IGD

6.2. Global Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravenous Mode of Delivery

Subcutaneous Mode of Delivery

6.3. Global Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hypogammaglobulinemia

Chronic Inflammatory demyelinating polyneuropathy (CIDP)

Immunodeficiency Disease

Myasthenia Gravis

Idiopathic Thrombocytopenic Purpura (ITP)

Other Applications

6.4. Global Immunoglobulins Market, Sub-Segmentation Of IGG (Immunoglobulin G), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

IVIG (Intravenous Immunoglobulin)

SCIG (Subcutaneous Immunoglobulin)

6.5. Global Immunoglobulins Market, Sub-Segmentation Of IGA (Immunoglobulin A), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal IGA

Polyvalent IGA

6.6. Global Immunoglobulins Market, Sub-Segmentation Of IGM (Immunoglobulin M), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal IGM

Polyvalent IGM

6.7. Global Immunoglobulins Market, Sub-Segmentation Of IGE (Immunoglobulin E), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Allergen-Specific IGE

Monoclonal IGE

6.8. Global Immunoglobulins Market, Sub-Segmentation Of IGD (Immunoglobulin D), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Research-Use IGD

Monoclonal IGD

7. Immunoglobulins Market Regional And Country Analysis

7.1. Global Immunoglobulins Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Immunoglobulins Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunoglobulins Market

8.1. Asia-Pacific Immunoglobulins Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunoglobulins Market

9.1. China Immunoglobulins Market Overview

9.2. China Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunoglobulins Market

10.1. India Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunoglobulins Market

11.1. Japan Immunoglobulins Market Overview

11.2. Japan Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunoglobulins Market

12.1. Australia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunoglobulins Market

13.1. Indonesia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunoglobulins Market

14.1. South Korea Immunoglobulins Market Overview

14.2. South Korea Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunoglobulins Market

15.1. Western Europe Immunoglobulins Market Overview

15.2. Western Europe Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunoglobulins Market

16.1. UK Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunoglobulins Market

17.1. Germany Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunoglobulins Market

18.1. France Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunoglobulins Market

19.1. Italy Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunoglobulins Market

20.1. Spain Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunoglobulins Market

21.1. Eastern Europe Immunoglobulins Market Overview

21.2. Eastern Europe Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunoglobulins Market

22.1. Russia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunoglobulins Market

23.1. North America Immunoglobulins Market Overview

23.2. North America Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunoglobulins Market

24.1. USA Immunoglobulins Market Overview

24.2. USA Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunoglobulins Market

25.1. Canada Immunoglobulins Market Overview

25.2. Canada Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunoglobulins Market

26.1. South America Immunoglobulins Market Overview

26.2. South America Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunoglobulins Market

27.1. Brazil Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunoglobulins Market

28.1. Middle East Immunoglobulins Market Overview

28.2. Middle East Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunoglobulins Market

29.1. Africa Immunoglobulins Market Overview

29.2. Africa Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunoglobulins Market Competitive Landscape And Company Profiles

30.1. Immunoglobulins Market Competitive Landscape

30.2. Immunoglobulins Market Company Profiles

30.2.1. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. CSL Behring LLC Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Grifols S. A. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Octapharma AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. China Biologic Products Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Immunoglobulins Market Other Major And Innovative Companies

31.1. Kedrion SpA

31.2. LFB SA

31.3. Biotest AG

31.4. Sanquin Blood Supply Foundation

31.5. ADMA Biologics Inc.

31.6. Option Care Health Inc.

31.7. Shanghai RAAS Blood Products Co. Ltd.

31.8. Antibody Solutions

31.9. Bio Products Laboratory Ltd.

31.10. Immunovant Inc.

31.11. Kamada Ltd.

31.12. Emergent BioSolutions Inc.

31.13. Fresenius Kabi AG

31.14. GlaxoSmithKline plc

31.15. Pfizer Inc.

32. Global Immunoglobulins Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunoglobulins Market

34. Recent Developments In The Immunoglobulins Market

35. Immunoglobulins Market High Potential Countries, Segments and Strategies

35.1 Immunoglobulins Market In 2029 - Countries Offering Most New Opportunities

35.2 Immunoglobulins Market In 2029 - Segments Offering Most New Opportunities

35.3 Immunoglobulins Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

Need tailored insights? Customise this report to fit your business goals.

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Immunoglobulins Market, Sub-Segmentation Of IGG (Immunoglobulin G), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Immunoglobulins Market, Sub-Segmentation Of IGA (Immunoglobulin A), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Immunoglobulins Market, Sub-Segmentation Of IGM (Immunoglobulin M), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Immunoglobulins Market, Sub-Segmentation Of IGE (Immunoglobulin E), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Immunoglobulins Market, Sub-Segmentation Of IGD (Immunoglobulin D), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Immunoglobulins Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Immunoglobulins Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Baxter International Inc. Financial Performance
  • Table 80: CSL Behring LLC Financial Performance
  • Table 81: Grifols S. A. Financial Performance
  • Table 82: Octapharma AG Financial Performance
  • Table 83: China Biologic Products Holdings Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Immunoglobulins Market, Sub-Segmentation Of IGG (Immunoglobulin G), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Immunoglobulins Market, Sub-Segmentation Of IGA (Immunoglobulin A), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Immunoglobulins Market, Sub-Segmentation Of IGM (Immunoglobulin M), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Immunoglobulins Market, Sub-Segmentation Of IGE (Immunoglobulin E), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Immunoglobulins Market, Sub-Segmentation Of IGD (Immunoglobulin D), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Immunoglobulins Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Immunoglobulins Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Baxter International Inc. Financial Performance
  • Figure 80: CSL Behring LLC Financial Performance
  • Figure 81: Grifols S. A. Financial Performance
  • Figure 82: Octapharma AG Financial Performance
  • Figure 83: China Biologic Products Holdings Inc. Financial Performance

Key Factors Fueling the Growth of the Budesonide Inhaler Market in 2025: Surge In Respiratory Disorders Fueling The Growth Of The Market Due To Increasing Air Pollution And Chronic Disease Prevalence

Read More About Key Factors Fueling the Growth of the Budesonide Inhaler Market in 2025: Surge In Respiratory Disorders Fueling The Growth Of The Market Due To Increasing Air Pollution And Chronic Disease Prevalence

Critical Market Drivers Shaping the Outlook for Calcitonin Gene-Related Peptide (CGRP) Inhibitors Market from 2025-2034: Increasing Prevalence Of Migraine Fueling The Growth Of The Market Due To Increasing Stress Levels And Improved Treatment Options

Read More About Critical Market Drivers Shaping the Outlook for Calcitonin Gene-Related Peptide (CGRP) Inhibitors Market from 2025-2034: Increasing Prevalence Of Migraine Fueling The Growth Of The Market Due To Increasing Stress Levels And Improved Treatment Options

Major Drivers Propelling the Growth oh theCandesartan Cilexetil Drug Market Forward: Surge In Hypertension Prevalence Fueling The Growth Of The Market Due To Increased Lifestyle Risks And Demand For Effective Management Solutions

Read More About Major Drivers Propelling the Growth oh theCandesartan Cilexetil Drug Market Forward: Surge In Hypertension Prevalence Fueling The Growth Of The Market Due To Increased Lifestyle Risks And Demand For Effective Management Solutions

Strategic Growth Drivers Shaping the Cardiotonic Agents Market Outlook 2025- 2034:Rise In Cardiovascular Diseases Driving The Growth Of The Market Due To Increasing Prevalence And Demand For Heart-Related Treatments

Read More About Strategic Growth Drivers Shaping the Cardiotonic Agents Market Outlook 2025- 2034:Rise In Cardiovascular Diseases Driving The Growth Of The Market Due To Increasing Prevalence And Demand For Heart-Related Treatments

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Immunity Boosting Food Products Market 2024 – By Product Source (Herbs And Species, Nuts And Seeds, Fruits And Vegetables, Dairy-Based Products, Prebiotics, Other Product Sources), By Form (Tablets, Capsules, Powder, Li...

View Report

Viral Vectors And Plasmid DNA Global Market Report 2025 – By Product (Plasmid DNA, Viral Vectors), By Disease (Infectious Diseases, Genetic Disorders, Cancer, Other Diseases), By Application (Gene And Cancer Therapies, V...

View Report

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2025 – By Technique (Competitive Assay, Sandwich Assay, Multiplex Detection Assay), By Application (Infectious Disease, Pregnancy And Fertility, Toxic...

View Report

Bi-Specific MAbS Global Market Report 2025 – By Type (Catumaxomab (Removab), Blinatumomab, Duligotumab, Emicizumab, Amivantamab, Faricimab, Teclistamab), By Product Type (In Vivo, In Vitro), By Indication (Cancer, Hemoph...

View Report

Immunochemistry Diagnostic Devices And Equipment Global Market Report 2025 – By Product Type (Immunochemistry Analyzers, Immunochemistry Stainers, Incubators, Microscopes, Centrifuges, Autoclaves, Consumables), By Consum...

View Report

Orphan Drugs Global Market Report 2025 – By Therapy Area (Oncology, Blood, Central Nervous System, Endocrine, Cardiovascular, Respiratory, Immunomodulatory), By Diseases Type (Oncology, Hematology, Neurology, Cardiovascu...

View Report

Drug Delivery Devices Global Market Report 2025 – By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Trans...

View Report

Autoimmune Disease Diagnosis Global Market Report 2025 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals, Others), By Test Type (Routine Laboratory Tests, Autoantibodie...

View Report

Frequently Asked Questions

Immunoglobins refer to glycoproteins, often known as antibodies, that are created by plasma cells (white blood cells). They play a crucial role in the immune response by selectively identifying and attaching to specific antigens, such as viruses or bacteria, and assisting in their eradication. For further insights on this market, request a sample here

The market major growth driver - Growing Geriatric Population Fuels Demand For Immunoglobulins Market. For further insights on this market, request a sample here

The immunoglobulins market size has grown strongly in recent years. It will grow from $18.85 billion in 2024 to $20.32 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increased prevalence of immunodeficiency disorders, growing geriatric population, rising adoption of immunoglobulins in hospitals, favorable government reimbursement plans, increasing prevalence of chronic and autoimmune diseases. The immunoglobulins market size is expected to see rapid growth in the next few years. It will grow to " $30.89 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to increasing investment for the development of advanced technologies, growing awareness about immunodeficiency therapies, rising preference among physicians for immunodeficiency therapies, increasing number of emerging markets, expansion of applications in sports and fitness. Major trends in the forecast period include development of wearable and smart compression devices, customization of compression therapy solutions, integration of compression therapy in wound care management, emphasis on patient comfort and compliance in compression therapy, collaboration between manufacturers and healthcare providers for improved patient outcomes. For further insights on this market, request a sample here

The immunoglobulins market covered in this report is segmented –
1) By Product: IGG, IGA, IGM, IGE, IGD.
2) By Mode Of Delivery: Intravenous Mode Of Delivery, Subcutaneous Mode Of Delivery
3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications Subsegments:
1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin), SCIG (Subcutaneous Immunoglobulin)
2) By IGA (Immunoglobulin A): Monoclonal IGA, Polyvalent IGA
3) By IGM (Immunoglobulin M): Monoclonal IGM, Polyvalent IGM
4) By IGE (Immunoglobulin E): Allergen-Specific IGE, Monoclonal IGE
5) By IGD (Immunoglobulin D): Research-Use IGD, Monoclonal IGD For further insights on this market, request a sample here

North America was the largest region in the immunoglobulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the immunoglobulins market include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited . For further insights on this market, request a sample here.

Major trends in this market include Innovative Product Launches Drive Growth in the U.S. Immunoglobulins Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Immunoglobulins Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top
\
Back to top